3-(1-Aminoethyl)phenol Sigma Aldrich Equivalent Supplier
Sourcing a Validated 3-(1-Aminoethyl)phenol Sigma Aldrich Equivalent
Procurement of 3-(1-Aminoethyl)phenol (CAS: 63720-38-7) for research and development requires a shift from catalog-based purchasing to direct manufacturer engagement. Catalog suppliers often repackage bulk chemical inventory, introducing potential variability in batch consistency and significant cost markups. For process chemistry and scale-up activities, securing a supply chain directly linked to the manufacturing process ensures traceability and specification adherence. NINGBO INNO PHARMCHEM CO.,LTD. operates as a direct source, eliminating intermediary handling that can compromise the integrity of hygroscopic or sensitive intermediates.
When evaluating a supplier for this meta-substituted phenol derivative, the primary focus must be on the synthesis route employed. Different synthetic pathways can yield varying impurity profiles, particularly regarding regioisomers. A validated supply chain provides transparency regarding the origin of starting materials and the reaction conditions used. This level of oversight is critical when transitioning from gram-scale laboratory experiments to kilogram-level pilot runs. Reliance on a global manufacturer with established quality control protocols mitigates the risk of project delays caused by out-of-specification materials.
Verifying Purity and Structural Integrity Against Industry Standards
Analytical verification is the cornerstone of accepting any chemical intermediate into a production workflow. For 3-(1-Aminoethyl)phenol, standard characterization involves High-Performance Liquid Chromatography (HPLC) and Gas Chromatography-Mass Spectrometry (GC-MS). The presence of the phenolic hydroxyl group and the primary amine functionality requires specific detection methods to quantify purity accurately. Impurities often include unreacted starting materials, over-alkylated byproducts, or positional isomers such as the para- or ortho-variants. Distinguishing 3-Hydroxy-Alpha-methylbenzylamine from its isomers requires high-resolution chromatographic separation.
Batch-specific Certificates of Analysis (COA) must detail the assay method, retention times, and integration parameters. Below is a comparison of typical specification parameters expected for pharmaceutical grade intermediates versus standard commercial grades:
| Parameter | Standard Commercial Grade | Validated Pharmaceutical Intermediate | Test Method |
|---|---|---|---|
| Assay (Purity) | > 95.0% | > 98.5% | HPLC (Area %) |
| Water Content | < 1.0% | < 0.5% | Karl Fischer |
| Related Substances | < 5.0% | < 1.5% | GC-MS / HPLC |
| Heavy Metals | Not Specified | < 10 ppm | ICP-MS |
| Residue on Ignition | < 0.5% | < 0.1% | Gravimetric |
Structural integrity is further confirmed through Nuclear Magnetic Resonance (NMR) spectroscopy, specifically looking at the proton shifts on the aromatic ring to confirm meta-substitution. The aminoethyl side chain should show characteristic quartet and doublet patterns corresponding to the chiral center, unless the material is supplied as a racemate. For projects requiring enantiomeric purity, chiral HPLC methods must be employed. Access to 3-(1-Aminoethyl)phenol or Alpha-methyl-3-hydroxybenzylamine with full spectral data ensures that the material matches the theoretical structure required for downstream synthesis.
Essential Regulatory Compliance and Safety Documentation for R&D Labs
Safety documentation must accompany every shipment to ensure compliance with laboratory safety standards and transport regulations. The Safety Data Sheet (SDS) should be updated according to the latest Globally Harmonized System (GHS) criteria. This document provides critical information on handling, storage, and emergency measures. For 3-(1-Aminoethyl)phenol, the SDS must accurately reflect the hazards associated with phenolic compounds and amines, including potential skin corrosion and toxicity upon ingestion or inhalation.
Quality assurance protocols extend beyond the final product test. It involves auditing the manufacturing site for adherence to Good Manufacturing Practices (GMP) where applicable, or at least ISO 9001 standards for chemical production. Documentation should include statements of origin, confirming that the materials do not contain animal-derived components if this is a constraint for the final pharmaceutical product. Transport classification is also vital; while many intermediates are non-hazardous for air freight, some amine-containing compounds may require specific UN classifications. Ensuring all paperwork aligns with local import regulations prevents customs delays.
Optimizing Lead Times, Costs, and Bulk Supply for 3-(1-Aminoethyl)phenol Procurement
Supply chain stability is a function of inventory management and production capacity. Catalog suppliers typically hold limited stock, leading to backorders when demand spikes. Direct manufacturers maintain raw material reserves and flexible reactor schedules to accommodate urgent requirements. Lead times for bulk quantities should be clearly defined, typically ranging from 2 to 4 weeks for standard inventory items, depending on the required quantity and packaging. Cost optimization is achieved by consolidating orders and selecting appropriate Incoterms that balance risk and expense.
Packaging options influence both cost and material stability. For hygroscopic compounds, double-lined polyethylene bags within fiber drums or sealed HDPE containers are standard. Nitrogen flushing may be required to prevent oxidation during storage and transit. When procuring in metric ton quantities, isotanks or flexible intermediate bulk containers (FIBCs) may be utilized to reduce packaging waste and unit cost. Logistics planning should account for temperature controls if the compound has a low melting point or thermal instability. Efficient procurement strategies involve forecasting annual usage to negotiate volume-based pricing tiers without compromising cash flow.
Partnering for Custom Synthesis and Long-Term Supply Agreements
Long-term projects benefit from strategic partnerships rather than transactional purchasing. A reliable chemical partner offers custom synthesis capabilities to modify the standard synthesis route if specific impurity profiles or isotopic labeling are required. NINGBO INNO PHARMCHEM CO.,LTD. supports scale-up activities by adjusting process parameters to maintain yield and purity as batch sizes increase. This collaboration allows for continuous improvement of the manufacturing process based on feedback from the R&D team.
Supply agreements should define key performance indicators such as on-time delivery, specification compliance rates, and communication protocols for deviation management. Having a dedicated technical account manager ensures that queries regarding batch data or process changes are resolved quickly. For critical path intermediates, securing a secondary supply source or validating a backup manufacturing line is a prudent risk mitigation strategy. Establishing a framework for regular quality reviews ensures that the material remains consistent over the lifecycle of the drug development program.
Maintaining a robust supply chain for key intermediates like Alpha-methyl-3-hydroxybenzylamine derivatives requires diligent vendor qualification and ongoing performance monitoring. By prioritizing technical data and manufacturing transparency over catalog convenience, procurement teams can ensure project continuity.
To request a batch-specific COA, SDS, or secure a bulk pricing quote, please contact our technical sales team.